Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of the Spermotrend Food Supplement in the Treatment of Male Infertility and Benign Prostatic Hyperplasia

NCT05222841 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT05222841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of the Spermotrend Food Supplement in the Treatment of Male Infertility and Benign Prostatic Hyperplasia
Lead sponsor
Catalysis SL
Phase
Phase 2/3
Overall status
Completed
Start date
June 15, 2021
Completion date
December 15, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, male infertility, spermatogenesis and semen disorders